Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

US-based patient monitoring technology developer BioIntelliSense received $45m last month in a series B round featuring University of Colorado healthcare system UCHealth as well as its CU Healthcare Innovation Fund. They were joined by Philips, Fresenius Medical Care, Pendrell Corporation, TripleTree Holdings and CU Healthcare Innovation Fund. The round followed a $25m series A featuring UCHealth, CU Healthcare Innovation Fund, Fresenius and TripleTree Holdings that closed in September 2020 together with a newer $12m round.
Canada-based vascular stent developer Fluid Biotech closed a $4.7m seed round yesterday that included University of Calgary’s UCeed Health Fund and UCeed Child Health and Wellness Fund. The round was co-led by Metis Innovative and ShangBay Capital and also featured Thin Air Labs, Wharton Alumni Angels, Amino Capital, Bluesky Equities, ThresholdImpact, Alabaster Capital and undisclosed pre-seed investors. Fluid had secured $840,000 in pre-seed funding from unnamed backers in February 2020.
Forefront RF, a…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.